// App-Quantinova.ai

e22041 : Circulating tumor cell (CTC) as a prognostic marker in primary lung cancer.

Researchers

Presenter

  • Kazue Yoneda

Principal Investigators

  • Fumihiro Tanaka

  • Nobuyuki Kondo

  • Chiharu Tabata

  • Takashi Nakano

  • Seiji Matsumoto

  • Yoshitomo Okumura

  • Noriaki Tsubota

  • Ayuko Sato

  • Tohru Tsujimura

  • Kozo Kuribayashi

  • Seiki Hasegawa

  • Masaki Hashimoto

  • Teruhisa Takuwa

Medical Centers

  • Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan

  • Hyogo College of Medicine, Nishinomiya, JapanDepartment of Pathology, Hyogo College of Medicine, Nishinomiya, JapanHyogo College of Medicine, Department of Thoracic Surgery, Nishinomiya, Japan

  • Hyogo Medcl Coll, Nishinomiya, Japan

  • Itami City Hospital, Itami, Japan

  • University of Occupational and Environmental Health, Kitakyushu, Japan

  • Department of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Japan

  • University of Occupational and Environmental Health, Kitakyushu, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved